173 related articles for article (PubMed ID: 30356125)
41. [Decreased pulmonary toxicity in continuous subcutaneous infusion and consecutive daily injection of peplomycin in testicular tumor patients].
Satake I; Tari K; Suzuki F; Yoshida S
Nihon Gan Chiryo Gakkai Shi; 1985 Dec; 20(10):2291-7. PubMed ID: 2420909
[No Abstract] [Full Text] [Related]
42. [Preliminary evaluation of the toxicity and effectiveness of chemotherapy using the VAB-6 protocol in the treatment of non-seminoma of the testis].
Madej G; Gigier A; Siedlecki P; Pieńkowski T
Nowotwory; 1987; 37(1):44-9. PubMed ID: 2442730
[No Abstract] [Full Text] [Related]
43. Bleomycin and scuba diving: to dive or not to dive?
Huls G; ten Bokkel Huinink D
Neth J Med; 2003 Feb; 61(2):50-3. PubMed ID: 12735422
[TBL] [Abstract][Full Text] [Related]
44. Cisplatin, etoposide and continuous infusion bleomycin in patients with testicular germ cell tumors: efficacy and toxicity data from a retrospective study.
Curigliano G; Spitaleri G; Magni E; Lorizzo K; De Cobelli O; Locatelli M; Fumagalli L; Adamoli L; Cossu Rocca M; Verri E; De Pas T; Jereczek-Fossa B; Martinelli G; Goldhirsch A; Nolè F
J Chemother; 2009 Dec; 21(6):687-92. PubMed ID: 20071294
[TBL] [Abstract][Full Text] [Related]
45. [Germ cell testicular tumors: understanding the kinetics of serum alpha-fetoprotein (AFP) during chemotherapy].
Riedinger JM; Eche N; Chevreau C; Fargeot P
Ann Biol Clin (Paris); 2008; 66(5):523-30. PubMed ID: 18957341
[TBL] [Abstract][Full Text] [Related]
46. Long-term outcome of patients with clinical stage I high-risk nonseminomatous germ-cell tumors 15 years after one adjuvant cycle of bleomycin, etoposide, and cisplatin chemotherapy.
Vidal AD; Thalmann GN; Karamitopoulou-Diamantis E; Fey MF; Studer UE
Ann Oncol; 2015 Feb; 26(2):374-7. PubMed ID: 25392157
[TBL] [Abstract][Full Text] [Related]
47. [Carboplatin-etoposide-bleomycine chemotherapy protocol in the treatment of patients with metastatic non-seminomatous germ-cell testicular tumours with good prognosis].
Jeremić B; Djurić Lj; Djordjević S; Cirović V; Milojević Lj; Stanisavljević B; Matović M; Mijatović Lj
Srp Arh Celok Lek; 1994; 122(9-10):257-9. PubMed ID: 17977429
[TBL] [Abstract][Full Text] [Related]
48. [Bleomycin-induced pneumonia].
Berger K; Göpfert A; Berkel H
Anasthesiol Intensivmed Notfallmed Schmerzther; 1996 Nov; 31(9):577-81. PubMed ID: 9063925
[TBL] [Abstract][Full Text] [Related]
49. Role of single-breath carbon monoxide-diffusing capacity in monitoring the pulmonary effects of bleomycin in germ cell tumor patients.
Comis RL; Kuppinger MS; Ginsberg SJ; Crooke ST; Gilbert R; Auchincloss JH; Prestayko AW
Cancer Res; 1979 Dec; 39(12):5076-80. PubMed ID: 91430
[TBL] [Abstract][Full Text] [Related]
50. Successful treatment of resistant germinal neoplasms with VP-16 and cisplatin: results of a Southeastern Cancer Study Group trial.
Hainsworth JD; Williams SD; Einhorn LH; Birch R; Greco FA
J Clin Oncol; 1985 May; 3(5):666-71. PubMed ID: 2582097
[TBL] [Abstract][Full Text] [Related]
51. Long-term followup results of 1 cycle of adjuvant bleomycin, etoposide and cisplatin chemotherapy for high risk clinical stage I nonseminomatous germ cell tumors of the testis.
Westermann DH; Schefer H; Thalmann GN; Karamitopoulou-Diamantis E; Fey MF; Studer UE
J Urol; 2008 Jan; 179(1):163-6. PubMed ID: 18001800
[TBL] [Abstract][Full Text] [Related]
52. Consensus Recommendations from the Spanish Germ Cell Cancer Group on the Use of High-dose Chemotherapy in Germ Cell Cancer.
González-Billalabeitia E; Sepúlveda JM; Maroto P; Aparicio J; Arranz JA; Esteban E; Gironés R; López-Brea M; Mendez-Vidal MJ; Pinto A; Sastre J; de Prado DS; Terrasa J; Vázquez S; Powles T; Beyer J; Castellano D; Del Muro XG;
Eur Urol Focus; 2017 Apr; 3(2-3):280-286. PubMed ID: 28753776
[TBL] [Abstract][Full Text] [Related]
53. Bilateral Lung Transplantation for Bleomycin-Associated Lung Injury.
Narayan V; Deshpande C; Bermudez CA; Golato JM; Lee JC; Diamond J; Vaughn DJ
Oncologist; 2017 May; 22(5):620-622. PubMed ID: 28360217
[TBL] [Abstract][Full Text] [Related]
54. Pulmonary alterations during BEP? Always be aware of BIP.
Sleijfer S
Onkologie; 2007 Jun; 30(6):291-2. PubMed ID: 17551251
[No Abstract] [Full Text] [Related]
55. Chemotherapy of male and female germ cell tumors.
Williams SD; Loehrer PJ; Nichols CR; Einhorn LN
Semin Oncol; 1992 Apr; 19(2 Suppl 5):19-23; discussion 23-4. PubMed ID: 1384139
[TBL] [Abstract][Full Text] [Related]
56. Effects of curcumin on bleomycin‑induced oxidative stress in malignant testicular germ cell tumors.
Cort A; Ozdemir E; Timur M; Ozben T
Mol Med Rep; 2012 Oct; 6(4):860-6. PubMed ID: 22825355
[TBL] [Abstract][Full Text] [Related]
57. Pituitary and testicular hormonal function after treatment for germ cell tumours.
Bosl GJ; Bajorunas D
Int J Androl; 1987 Feb; 10(1):381-4. PubMed ID: 2438229
[TBL] [Abstract][Full Text] [Related]
58. Long-term effects on renal function and blood pressure of treatment with cisplatin, vinblastine, and bleomycin in patients with germ cell cancer.
Hansen SW; Groth S; Daugaard G; Rossing N; Rørth M
J Clin Oncol; 1988 Nov; 6(11):1728-31. PubMed ID: 2460594
[TBL] [Abstract][Full Text] [Related]
59. [Raynaud's disease after treatment with bleomycin and vinblastine].
Dzieza-Lalowicz I; Mykała-Cieśla J
Pol Tyg Lek; 1986 Feb; 41(7):218-9. PubMed ID: 2423995
[No Abstract] [Full Text] [Related]
60. A population-based study of pulmonary monitoring and toxicity for patients with testicular cancer treated with bleomycin.
Raphael MJ; Lougheed MD; Wei X; Karim S; Robinson AG; Bedard PL; Booth CM
Curr Oncol; 2020 Dec; 27(6):291-298. PubMed ID: 33380860
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
